ArticleInternational journal of biological sciences2024

Combination of TrxR1 inhibitor and lenvatinib triggers ROS-dependent cell death in human lung cancer cells.

Peisen Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.